

Author: Singh Rakesh Lange Thilo Kim Kyu Brard Laurent
Publisher: Springer Publishing Company
ISSN: 0167-6997
Source: Investigational New Drugs, Vol.29, Iss.1, 2011-02, pp. : 63-72
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The Development of Pro-Apoptotic Cancer Therapeutics
Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. :


Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. :




By Fimognari Carmela Nüsse Michael Iori Renato Cantelli-Forti Giorgio Hrelia Patrizia
Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. :